bluedoor data·H-1B Jobs API·bluedoor.sh ->

Home / Companies / Boston Pharmaceuticals Inc / Trends

Boston Pharmaceuticals Inc H-1B trends

Quarterly LCA aggregate trend points for Boston Pharmaceuticals Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.

Summary

H-1B LCA filings for Boston Pharmaceuticals Inc span 2020 Q1 to 2026 Q2, peaking at 2 filings in 2022 Q4.

The most recent reported period (2026 Q2) shows 1 filings.

LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.

PeriodLCA countRole titlesSOC codesAvg wage lowAvg prevailingCertifiedCertification rate
2020 Q1111$133,000$131,8931100.0%
2022 Q1111$220,000$109,6991100.0%
2022 Q4212$167,346$150,176150.0%
2023 Q3111$188,780$150,1761100.0%
2026 Q2111$206,800$206,4401100.0%

Frequently asked questions

How have H-1B filings for Boston Pharmaceuticals Inc changed over time?
H-1B LCA filings for Boston Pharmaceuticals Inc span 2020 Q1 to 2026 Q2, peaking at 2 filings in 2022 Q4. The most recent reported period (2026 Q2) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API

Rendered from the bluedoor H-1B Jobs API. Reproduce it:

GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=boston+pharmaceuticals+inc&metric=lca_countJSON